Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This paper analyzes the policy components that contribute to the programmatic success of flu and Tdap pregnancy vaccine programs in three high-income countries, including the United States. Key pillars to increased vaccination coverage include Health Authority accountability, facilitated patient access to vaccination, healthcare professional accountability and engagement, awareness of the burden and severity of diseases, and finally, belief in the benefits of pregnancy vaccination. In the US, given the higher diversity of stakeholders, a multi-stakeholder approach with calls to action from the CDC and endorsement from other scientific societies were key to uptake of vaccinations in pregnancy. It is recommended that maternal task forces reinforce these messages, disseminate toolkits, and that partners address barriers that stand in the way of vaccination, including ensuring that vaccination clinics are convenient for pregnant woman. Successful programs do not require implementation of all components; instead, public health experts should use these as components as guiding tools that can be refined depending on the specificities of the healthcare system in place.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.